CHS Pharma Inc.
BioTech/Drugs - N/A, , US
CHS Pharma Inc. Employees
CHS Pharma Inc. Senior Management
CHS Pharma Inc. Details
CHS Pharma Inc. on Feb. 2013 acquired its Intellectual Property Portfolio from Florida Atlantic University and Hospital for Special Surgery. The IP portfolio is considered a platform technology and currently consists of 4 issued patents, 2 allowed, and 8 applications pending. The mentioned portfolio covers drug candidates for treatments of Actinic Keratosis (Basal and Squamous cell Carcinomas in EU patent), Dry Macular Degeneration, Myocardial Infarction, and Ischemic Stroke. CHS's corporate development strategy is to develop the drug candidates up to Phase II clinical studies and at that point in time either form a strategic partnership or license the technology to other pharmaceutical companies.
CHS Pharma Inc. Technologies
Email Providers
Outlook
Other
Mobile Friendly
Hosting
GoDaddy Hosting